Cadrenal Therapeutics, Inc.
CVKD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937993
In the last 90 days, Cadrenal Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 19 institutions reported holding it in 13F filings for Q2 2026, worth $379.6K in total; no superinvestor holds it.
Holders of 5% or more of CVKD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cadrenal Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Pham Quang X | 13D | 23.60%421.0K shares | New | Jan 29, 20251 filing | Jan 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Cadrenal Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 20251:05 PM ET | Havlickova 648 a.s.and 2 others | 13G/A | 4.39%78.3K shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 29, 20257:29 PM ET | Pham Quang Xand 1 other | 13D | 23.60%421.0K shares | New | Jan 23, 2025 | SEC |
| Jan 15, 20254:23 PM ET | Murphy John Raymond | 13G/A | 2.96%53.2K shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cadrenal Therapeutics, Inc. shares.
No Form 144 notices for Cadrenal Therapeutics, Inc. are on file.